文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期,新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

研究miRNA-137-3p/383-5p/PGC-1α信号轴抗心肌肥厚的治疗潜力

Investigating the Therapeutic Potential of miRNA-137-3p/383-5p/PGC-1α Signalling Nexus Against Cardiac Hypertrophy.

作者信息

Hussain Khadam, Khurram Somia, Yousaf Muhammad, Ishtiaq Ayesha, Mushtaq Iram, Ali Tahir, Murtaza Iram

机构信息

Department of Biochemistry, Signal Transduction Laboratory, Faculty of Biological Sciences, Quaid-I-Azam University, Islamabad, 45320, Pakistan.

Institute of Chemical Biology, Shenzhen Bay Laboratory, Shenzhen, China.

出版信息

J Cardiovasc Transl Res. 2025 Jun 23. doi: 10.1007/s12265-025-10636-9.


DOI:10.1007/s12265-025-10636-9
PMID:40551059
Abstract

Pathological growth of cardiomyocytes known as cardiac hypertrophy (CH). Differential expressions of miRNAs have an immense therapeutic potential against cardiac hypertrophy. The current study aim is to evaluate the therapeutic potential of miRNA-137-3p/383-5p in cardiac hypertrophy by regulation of PGC-1α signaling nexus. Silencing of pro-hypertrophic miRNAs e.g. miR-137-3p and miR-383-5p leads to the restoration of their common target gene PGC-1α in hypertrophic cells. Interestingly, the results of this invivo study showed the cardioprotective effects of these antagomirs. Moreover, PGC-1α associated signaling events e.g. fatty acid oxidation (Cpt1a, Cpt1b), mitochondria membrane potential (MMP), mitochondrial reactive oxygen species (mtROS), oxidative phosphorylation (Ndufa6, Atp5me), apoptosis (Bcl-2, BAX), antioxidants (SOD, GSH, CAT), mitochondrial dynamic (Mfn-2, Drp-1) were significantly restored in the treated groups of miRNA antagomirs. Conclusively, this study uncovers that the pharmacological inhibition of miR-137-3p and miR-383-5p have a potential to rescue from the cardiac hypertrophy by regulation of PGC-1α signaling nexus.

摘要

被称为心肌肥大(CH)的心肌细胞病理性生长。微小RNA(miRNA)的差异表达在对抗心肌肥大方面具有巨大的治疗潜力。当前研究的目的是通过调节PGC-1α信号通路来评估miRNA-137-3p/383-5p在心肌肥大中的治疗潜力。促肥大性miRNA(如miR-137-3p和miR-383-5p)的沉默导致其共同靶基因PGC-1α在肥大细胞中得以恢复。有趣的是,这项体内研究的结果显示了这些拮抗剂的心脏保护作用。此外,在miRNA拮抗剂治疗组中,与PGC-1α相关的信号事件,如脂肪酸氧化(Cpt1a、Cpt1b)、线粒体膜电位(MMP)、线粒体活性氧(mtROS)、氧化磷酸化(Ndufa6、Atp5me)、细胞凋亡(Bcl-2、BAX)、抗氧化剂(SOD、GSH、CAT)、线粒体动力学(Mfn-2、Drp-1)均得到显著恢复。总之,本研究揭示了对miR-137-3p和miR-383-5p的药理学抑制有可能通过调节PGC-1α信号通路来挽救心肌肥大。

相似文献

[1]
Investigating the Therapeutic Potential of miRNA-137-3p/383-5p/PGC-1α Signalling Nexus Against Cardiac Hypertrophy.

J Cardiovasc Transl Res. 2025-6-23

[2]
Improvement Effect of Shengxian Decoction on Cardiac Toxicity Induced by Arsenic Trioxide in Rats.

J Ethnopharmacol. 2025-6-19

[3]
MicroRNAs in oral fluids (saliva and gingival crevicular fluid) as biomarkers in orthodontics: systematic review and integrated bioinformatic analysis.

Prog Orthod. 2021-10-11

[4]
Non-invasive biomarkers for brain aging: the role of autophagy-related microRNAs in plasma exosomes.

Front Mol Neurosci. 2025-6-6

[5]
Exploring the Mechanism of Acupuncture in Improving Ovarian Function in Rats with Poor Ovarian Response Using High-Throughput Sequencing.

Comb Chem High Throughput Screen. 2025

[6]
Exploring the complex interplay between oral infection, periodontitis, and robust microRNA induction, including multiple known oncogenic miRNAs.

mSystems. 2025-6-25

[7]
miRNA dysregulation in Duchenne muscular dystrophy comorbidities.

World J Exp Med. 2025-6-20

[8]
Zhen-wu-tang alleviates nephrotic syndrome by upregulating 5-HTR1B to activate AMPK/PGC-1α-mediated mitochondrial biogenesis.

J Ethnopharmacol. 2025-6-16

[9]
[Omics Study of Ovarian Malignancies: From Urine Metabolomic Profile to Minimally Invasive MicroRNA Markers].

Mol Biol (Mosk). 2025

[10]
Characterization and analysis of MicroRNA during leg muscle development in embryonic stage of daozhou grey goose.

Poult Sci. 2025-6-5

本文引用的文献

[1]
Cardioprotective effect of tetra(aniline) containing terpolymers through miR-15a-5p and MFN-2 regulation against hypertrophic responses.

Arch Biochem Biophys. 2023-10-1

[2]
Emerging concepts of miRNA therapeutics: from cells to clinic.

Trends Genet. 2022-6

[3]
Cardiac Fibroblast-Specific Knockout of PGC-1α Accelerates AngII-Induced Cardiac Remodeling.

Front Cardiovasc Med. 2021-6-16

[4]
Adeno-associated virus-mediated delivery of anti-miR-199a tough decoys attenuates cardiac hypertrophy by targeting .

Mol Ther Nucleic Acids. 2020-11-17

[5]
Qingda granule attenuates angiotensin II-induced cardiac hypertrophy and apoptosis and modulates the PI3K/AKT pathway.

Biomed Pharmacother. 2021-1

[6]
Metformin protects against myocardial ischemia-reperfusion injury and cell pyroptosis via AMPK/NLRP3 inflammasome pathway.

Aging (Albany NY). 2020-11-24

[7]
PGC-1, Inflammation, and Oxidative Stress: An Integrative View in Metabolism.

Oxid Med Cell Longev. 2020-3-9

[8]
MicroRNA and Cardiovascular Diseases.

Balkan Med J. 2020-2-5

[9]
Plantamajoside attenuates isoproterenol-induced cardiac hypertrophy associated with the HDAC2 and AKT/ GSK-3β signaling pathway.

Chem Biol Interact. 2019-4-19

[10]
Nrf2 deficiency aggravates Angiotensin II-induced cardiac injury by increasing hypertrophy and enhancing IL-6/STAT3-dependent inflammation.

Biochim Biophys Acta Mol Basis Dis. 2019-1-19

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索